Eun Kyeung Song1. 1. College of Nursing, University of Kentucky, Lexington, KY, USA. gracesong@uky.edu
Abstract
BACKGROUND: Although a low-sodium diet (LSD) is important in self-management of patients with heart failure (HF), the impact of LSD on event-free survival has not been investigated. Depressive symptoms predict worse event-free survival, in part, by affecting adherence to self-management. However, there are few investigations of the relationship among depressive symptoms, adherence to the LSD, and event-free survival. PURPOSE: The purpose of this study was to determine the relationships among adherence to the LSD, depressive symptoms, and event-free survival. METHODS: A total of 254 patients (57% male, 62 ± 14 years, 52% New York Heart Association class III/IV, ejection fraction of 36% ± 14%) were recruited from outpatient HF clinics in Korea. Twenty-four-hour urinary sodium excretion was collected as an indicator of patient adherence to the LSD. Patients were grouped based on the cut point of 3 g of urinary sodium excretion. Depressive symptoms were assessed by the Korean version of Beck Depression Inventory, and patients were split into 2 groups at the cutoff of the Korean version of Beck Depression Inventory. Event-free survival for 12 months was determined by medical records. Hierarchical Cox proportional hazards regression was used to determine the association of depressive symptoms and adherence to 3-g sodium intake on event-free survival. RESULTS: After controlling for age, sex, etiology of HF, body mass index, New York Heart Association class, ejection fraction, N-terminal B-type natriuretic peptide, and total comorbidity score, nonadherence to 3-g sodium intake (hazard ratio = 1.56, 95% confidence interval = 1.05-2.32) and depressive symptoms (hazard ratio = 2.21, 95% confidence interval = 1.47-3.33) independently predicted event-free survival. Patients with sodium intake higher than 3 g and with depressive symptoms demonstrated a 3.7 times higher risk for cardiac events compared with patients with sodium intake lower than 3 g and without depressive symptoms (P < .001). CONCLUSION: Improvement of adherence to the LSD and treatment for depressive symptoms could improve event-free survival.
BACKGROUND: Although a low-sodium diet (LSD) is important in self-management of patients with heart failure (HF), the impact of LSD on event-free survival has not been investigated. Depressive symptoms predict worse event-free survival, in part, by affecting adherence to self-management. However, there are few investigations of the relationship among depressive symptoms, adherence to the LSD, and event-free survival. PURPOSE: The purpose of this study was to determine the relationships among adherence to the LSD, depressive symptoms, and event-free survival. METHODS: A total of 254 patients (57% male, 62 ± 14 years, 52% New York Heart Association class III/IV, ejection fraction of 36% ± 14%) were recruited from outpatient HF clinics in Korea. Twenty-four-hour urinary sodium excretion was collected as an indicator of patient adherence to the LSD. Patients were grouped based on the cut point of 3 g of urinary sodium excretion. Depressive symptoms were assessed by the Korean version of Beck Depression Inventory, and patients were split into 2 groups at the cutoff of the Korean version of Beck Depression Inventory. Event-free survival for 12 months was determined by medical records. Hierarchical Cox proportional hazards regression was used to determine the association of depressive symptoms and adherence to 3-g sodium intake on event-free survival. RESULTS: After controlling for age, sex, etiology of HF, body mass index, New York Heart Association class, ejection fraction, N-terminal B-type natriuretic peptide, and total comorbidity score, nonadherence to 3-g sodium intake (hazard ratio = 1.56, 95% confidence interval = 1.05-2.32) and depressive symptoms (hazard ratio = 2.21, 95% confidence interval = 1.47-3.33) independently predicted event-free survival. Patients with sodium intake higher than 3 g and with depressive symptoms demonstrated a 3.7 times higher risk for cardiac events compared with patients with sodium intake lower than 3 g and without depressive symptoms (P < .001). CONCLUSION: Improvement of adherence to the LSD and treatment for depressive symptoms could improve event-free survival.
Authors: Misook L Chung; Debra K Moser; Terry A Lennie; Linda Worrall-Carter; Brooke Bentley; Robin Trupp; Deborah S Armentano Journal: J Card Fail Date: 2006-10 Impact factor: 5.712
Authors: Thomas Rutledge; Veronica A Reis; Sarah E Linke; Barry H Greenberg; Paul J Mills Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094
Authors: Terry A Lennie; Eun Kyeung Song; Jia-Rong Wu; Misook L Chung; Sandra B Dunbar; Susan J Pressler; Debra K Moser Journal: J Card Fail Date: 2011-01-21 Impact factor: 5.712
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher Journal: Circulation Date: 2008-09-29 Impact factor: 29.690
Authors: Terry A Lennie; Linda Worrall-Carter; Muna Hammash; Jan Odom-Forren; Lynn P Roser; Carol S Smith; Robin Trupp; Misook L Chung; Debra K Moser Journal: Prog Cardiovasc Nurs Date: 2008